FDA Approves Kirsty (insulin aspart-xjhz), an Interchangeable ...
Kirsty is a rapid-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Kirsty will be available as a single-patient-use prefilled …
FDA Approves Kirsty as First Interchangeable Insulin Aspart ...
Jul 15, 2025 · The FDA has approved Kirsty, the first interchangeable insulin aspart biosimilar, enhancing access to affordable diabetes care for millions.
KIRSTY - accessdata.fda.gov
Use KIRSTY in accordance with the insulin pump system’s instructions for use. Train patients using continuous subcutaneous insulin fusion pump therapy to administer insulin by injection …
Kirsty: Package Insert / Prescribing Information - Drugs.com
Sep 18, 2025 · Kirsty package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Kirsty - Wikipedia
Kirsty or Kirstie is a feminine given name and nickname. [1][2] It is a Scottish diminutive of Christine in English-speaking countries and is also linked to Kirsten — the Scandinavian …
Kirsty, an Interchangeable Biosimilar to Novolog, Gets FDA ...
Jul 17, 2025 · The FDA has approved Kirsty (insulin aspart-xjhz), an interchangeable biosimilar to Novolog, to improve glycemic control in diabetes mellitus.
FDA approves Biocon BLA for Kirsty | The Pharmaletter
Jul 16, 2025 · The US Food and Drug Administration has approved the first rapid-acting interchangeable biosimilar product, Kirsty (insulin aspart-xjhz), as a 3 mL single-patient-use …